studiedDrug

URI: https://gptkb.org/prop/studiedDrug
47 triples
GPTKB property
Alternative names (1)
testedDrug
Random triples
Subject Object
gptkb:Solidarity_trial_(WHO) gptkb:lopinavir/ritonavir
gptkb:Rivaroxaban_Once_Daily_Oral_Direct_Factor_Xa_Inhibition_Compared_with_Vitamin_K_Antagonism_for_Prevention_of_Stroke_and_Embolism_Trial_in_Atrial_Fibrillation gptkb:rivaroxaban
gptkb:RE-LY_trial gptkb:warfarin
gptkb:VISION_trial 177Lu-PSMA-617
gptkb:COVID-19_Solidarity_Trial_(WHO) gptkb:interferon_beta-1a
gptkb:COVID-19_Solidarity_Trial_(WHO) gptkb:lopinavir/ritonavir
gptkb:PolyHeme_Phase_III_Clinical_Trial gptkb:PolyHeme
gptkb:Adaptive_COVID-19_Treatment_Trial_1 placebo
gptkb:Canakinumab_Anti-inflammatory_Thrombosis_Outcomes_Study gptkb:canakinumab
gptkb:JULIET_trial gptkb:tisagenlecleucel
gptkb:REDUCE-IT gptkb:icosapent_ethyl
gptkb:SURPASS-3 gptkb:tirzepatide
gptkb:SURPASS-2 gptkb:tirzepatide
gptkb:ACTT-1 gptkb:remdesivir
gptkb:Oxygent_Clinical_Trials Oxygent
gptkb:Solidarity_trial_(WHO) gptkb:interferon_beta-1a
gptkb:IMpower150 gptkb:bevacizumab
gptkb:CheckMate_227 gptkb:nivolumab
gptkb:IMpower150 gptkb:carboplatin
gptkb:PACIFIC_trial gptkb:durvalumab
Please wait…